Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 31Recruiting 13Active not recruiting 9Terminated 8Unknown 6Not yet recruiting 5Withdrawn 3No longer available 2Suspended 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Carcinoma, Renal Cell 3Clear-cell metastatic renal cell carcinoma 1Advanced Renal Cell Carcinoma (aRCC) 1Advanced Renal Cell Carcinoma (RCC) 1

Interventions

Gemcitabine 13Radiotherapy 12Androgen Antagonists 12Specimen Handling 11Magnetic Resonance Spectroscopy 10pembrolizumab 9Nivolumab 8toripalimab 7darolutamide 7Drug Therapy 7Radiosurgery 6Docetaxel 6Cystectomy 6enzalutamide 5apalutamide 5Mitomycin 5Cisplatin 5Axitinib 5Abiraterone Acetate 5disitamab vedotin 4cabozantinib 4abiraterone 4Pluvicto 4Cyclophosphamide 4tislelizumab 3lenvatinib 3fludarabine 3cemiplimab 3Sunitinib 3Standard of Care 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Axitinib × Genitourinary × Clear all
NCT07630363 2026-06-05

PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1/2 Not yet recruiting
40 enrolled
Genitourinary

Advanced Renal Cell Carcinoma (RCC)

NCT07500831 2026-03-30

Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma

Qilu Hospital of Shandong University

Phase NA Not yet recruiting
43 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

SWOG Cancer Research Network

Phase 3 Not yet recruiting
718 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07277972 2025-12-11

Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
36 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT07159191 2025-09-08

Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

Peking Union Medical College Hospital

Phase 2 Not yet recruiting
30 enrolled
Genitourinary

Advanced Renal Cell Carcinoma (aRCC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡